Personalised 3D Assessment of Trochanteric Soft Tissues Improves HIP Fracture Classification Accuracy.


Journal

Annals of biomedical engineering
ISSN: 1573-9686
Titre abrégé: Ann Biomed Eng
Pays: United States
ID NLM: 0361512

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 08 08 2021
accepted: 19 01 2022
pubmed: 2 2 2022
medline: 26 3 2022
entrez: 1 2 2022
Statut: ppublish

Résumé

Passive soft tissues surrounding the trochanteric region attenuate fall impact forces and thereby control hip fracture risk. The degree of attenuation is related to Soft Tissue Thickness (STT). STT at the neutral hip impact orientation, estimated using a regression relation in body mass index (BMI), was previously shown to influence the current absolute risk of hip fracture (ARF0) and its fracture classification accuracy. The present study investigates whether fracture classification using ARF0 improves when STT is determined from the subject's Computed-Tomography (CT) scans (i.e. personalised) in an orientation-specific (i.e. 3D) manner. STT is calculated as the shortest distance along any impact orientation between a semi-automatically segmented femur surface and an automatically segmented soft tissue/air boundary. For any subject, STT along any of the 33 impact orientations analysed always exceeds the value estimated using BMI. Accuracy of fracture classification using ARF0 improves when using personalised 3D STT estimates (AUC = 0.87) instead of the BMI-based STT estimate (AUC = 0.85). The improvement is smaller (AUC = 0.86) when orientation-specificity of CT-based STT is suppressed and is nil when personalisation is suppressed instead. Thus, fracture classification using ARF0 improves when CT is used to personalise STT estimates and improves further when, in addition, the estimates are orientation specific.

Identifiants

pubmed: 35103867
doi: 10.1007/s10439-022-02924-1
pii: 10.1007/s10439-022-02924-1
pmc: PMC8847196
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

303-313

Subventions

Organisme : Engineering and Physical Sciences Research Council
ID : EP/K03877X/1
Organisme : Engineering and Physical Sciences Research Council
ID : EP/S032940/1
Organisme : Horizon 2020 Framework Programme
ID : H2020-INFRAEDI-2018-1/823712
Organisme : Horizon 2020 Framework Programme
ID : H2020-WIDESPREAD-2018-01/857533

Informations de copyright

© 2022. The Author(s).

Références

Ann Biomed Eng. 2005 Feb;33(2):248-54
pubmed: 15771279
J Bone Miner Res. 2007 Jun;22(6):825-31
pubmed: 17352651
Osteoporos Int. 2017 Oct;28(10):2791-2800
pubmed: 28748387
Cochrane Database Syst Rev. 2014 Mar 31;(3):CD001255
pubmed: 24687239
J Biomech. 2014 Nov 7;47(14):3531-8
pubmed: 25261321
Med Eng Phys. 2008 May;30(4):444-53
pubmed: 17627862
J Biomech Eng. 1995 Nov;117(4):409-13
pubmed: 8748522
J Clin Endocrinol Metab. 2009 Feb;94(2):491-6
pubmed: 19017753
J Appl Biomech. 2021 Nov 15;:1-9
pubmed: 34784585
Comput Methods Biomech Biomed Engin. 2014;17(3):204-9
pubmed: 22452517
J Biomech. 2008 Sep 18;41(13):2834-42
pubmed: 18718597
J Bone Miner Res. 2019 Oct;34(10):1837-1850
pubmed: 31163090
J Orthop Res. 1995 Nov;13(6):956-62
pubmed: 8544034
J Biomech. 2013 Apr 5;46(6):1140-6
pubmed: 23411114
Osteoporos Int. 2016 Feb;27(2):549-58
pubmed: 26286626
Osteoporos Int. 2014 Jan;25(1):251-63
pubmed: 23719860
Biomech Model Mechanobiol. 2019 Apr;18(2):301-318
pubmed: 30276488
Curr Osteoporos Rep. 2018 Jun;16(3):216-223
pubmed: 29656377
J Biomech. 2004 Jan;37(1):27-35
pubmed: 14672565
Clin Biomech (Bristol, Avon). 2019 Aug;68:137-143
pubmed: 31202100
Osteoporos Int. 2016 Sep;27(9):2815-2822
pubmed: 27108118
Osteoporos Int. 2012 Feb;23(2):513-20
pubmed: 21344243
J Biomech. 2021 Mar 5;117:110254
pubmed: 33493711
J Biomech. 2018 Jan 3;66:111-118
pubmed: 29153707
Accid Anal Prev. 2009 May;41(3):642-50
pubmed: 19393817
J Clin Densitom. 2014 Jan-Mar;17(1):54-9
pubmed: 23465643
J Biomech. 2007;40(13):2982-9
pubmed: 17434172
J Biomech Eng. 1991 Nov;113(4):366-74
pubmed: 1762432
J Biomech. 2003 Jul;36(7):897-904
pubmed: 12757797
Calcif Tissue Int. 1993 Feb;52(2):85-9
pubmed: 8443696
J Biomech. 2008;41(9):1969-77
pubmed: 18513728
J Biomech. 1999 Sep;32(9):993-8
pubmed: 10460138
J Biomech. 1996 Jun;29(6):807-11
pubmed: 9147979

Auteurs

Alessandra Aldieri (A)

PolitoBIOMed Lab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Department of Industrial Engineering, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Laboratorio di Tecnologia Medica, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Mara Terzini (M)

PolitoBIOMed Lab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.

Alberto L Audenino (AL)

PolitoBIOMed Lab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.

Cristina Bignardi (C)

PolitoBIOMed Lab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.

Margaret Paggiosi (M)

INSIGNEO Institute for In Silico Medicine, University of Sheffield, Pam Liversidge Building, Sheffield, S1 3JD, UK.
Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK.

Richard Eastell (R)

INSIGNEO Institute for In Silico Medicine, University of Sheffield, Pam Liversidge Building, Sheffield, S1 3JD, UK.
Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK.

Marco Viceconti (M)

Department of Industrial Engineering, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Laboratorio di Tecnologia Medica, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Pinaki Bhattacharya (P)

INSIGNEO Institute for In Silico Medicine, University of Sheffield, Pam Liversidge Building, Sheffield, S1 3JD, UK. p.bhattacharya@sheffield.ac.uk.
Department of Mechanical Engineering, University of Sheffield, Sheffield, UK. p.bhattacharya@sheffield.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH